24.05.2012 - Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the U.S...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)